AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Using sentiment indicators with index level data combines psychology and price to strengthen analysis. This overview provides steps to integrate both streams.
26,333 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
GL Homes’ Riverland community demonstrates how interconnected design and amenities sustain sales momentum in a rising...
As SpaceX captures headlines, a quieter but powerful growth wave is building in quantum computing. This guide highlig...
As rates likely rise this year, stocks face a new environment. This guide breaks down what that means for the S&P 500...
A zero-premium Part D plan can still trigger the IRMAA surcharge, adding as much as $91 a month for certain retirees....
A Danish archaeological drill near Aarhus uncovers a 1,000-year-old massive textile factory, underscoring Viking indu...
Cynthia Lummis gave clarity on timing for the CLARITY Act, but the Senate path remains uncertain as lawmakers juggle ...
Metaplanet's shares have fallen 88% over the past year, while its Bitcoin holdings top 40,000 BTC. The mismatch betwe...
Elon Musk signals a shift in hiring, prioritizing conversation over credentials with a rule he describes as don’t loo...
A troubling pattern emerges when vulnerable residents are moved into unlicensed homes. This article breaks down the r...
Aave's price surge near $94.32 on June 27 sparked talk that DeFi lending is entering a bank-like phase, with governan...
U.S. Bancorp is emerging as a premier retirement safe haven thanks to a steady dividend, solid capital position and e...